oxygen(2-);samarium(3+)

Modify Date: 2024-01-02 18:47:44

oxygen(2-);samarium(3+) structure	Common Name	oxygen(2-);samarium(3+)
	CAS Number	12060-58-1	Molecular Weight	348.718
	Density	8.347	Boiling Point	N/A
	Molecular Formula	O₃Sm₂	Melting Point	2325ºC
	MSDS	Chinese USA	Flash Point	N/A

Name	Samarium oxide
Synonym	More Synonyms

Density	8.347
Melting Point	2325ºC
Molecular Formula	O₃Sm₂
Molecular Weight	348.718
Exact Mass	351.824158
PSA	43.37000
Index of Refraction	1.97

oxygen(2-);samarium(3+) MSDS(Chinese)

CHEMICAL IDENTIFICATION

RTECS NUMBER :: VP3153000

CHEMICAL NAME :: Samarium oxide

CAS REGISTRY NUMBER :: 12060-58-1

LAST UPDATED :: 199701

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: O3-Sm2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >5 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: ATDAEI Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- Volume(issue)/page/year: 12,627,1993

Personal Protective Equipment	Eyeshields;Gloves
Hazard Codes	T+
Safety Phrases	S22-S24/25
RIDADR	NONH for all modes of transport
WGK Germany	2
RTECS	VP3153000
HS Code	2846901940

HS Code	2846901940

Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.

Int. J. Pharm. 349(1-2) , 24-9, (2008)

The fate of two colon-specific formulations developed in our previous study was investigated using a gamma scintigraphic imaging method. The formulations contained paracetamol and samarium oxide (Sm2O...

Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet constant-release drug delivery system.

Int. J. Pharm. 281(1-2) , 3-10, (2004)

This paper is a report from a pharmacoscintigraphic study with an Egalet constant-release system containing caffeine and natural abundance samarium oxide. First the formulation was tested in vitro to ...

Oral delivery of antisense oligonucleotides in man.

J. Pharm. Sci. 97(1) , 225-36, (2008)

Treatment of systemic disease with phosphorothioate antisense oligonucleotides (PS ASOs) has been accomplished using local or parenteral routes of administration to date. This report describes, for th...

MFCD00011237

EINECS 235-043-6

Samarium(III) oxide

oxygen(2-),samarium(3+)

Samarium Oxide